DNA Analysis of Blood and Tissue From Patients With Lung Cancer
Massachusetts General Hospital · with National Cancer Institute (NCI) · NCT00471978
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–120 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 15000
- US sites recruiting
- 2
- Study start
- September 2005
- Record last updated
- October 7, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help the study of cancer in the future.
PURPOSE: This clinical trial is analyzing the DNA in blood and tissue samples from patients with lung cancer.
Conditions: Lung Cancer
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
DISEASE CHARACTERISTICS
- Patient:
- Newly diagnosed primary lung cancer
- Patient at Massachusetts General Hospital (MGH) or Boston Medical Center Cancer Center
PATIENT CHARACTERISTICS
- Not specified
PRIOR CONCURRENT THERAPY
- Not specified
EXCLUSIONS
Vulnerable populations are excluded. Patients with metastasis from another site to lung or mesothelioma are excluded.
Recruiting US locations
Massachusetts General Hospital
Boston, MA 02114
Site contact: Clinical Trials Office - Massachusetts General Hospital · 877-726-5130
Harvard School of Public Health
Boston, MA 02115
Site contact: David C. Christiani, MD · 617-726-9274
Similar studies in Massachusetts
All healthy volunteers studies in Massachusetts →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001
Haya Therapeutics, Inc.
- Location
- Boston, MA + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Boston, MA + 49 other US sites
- Eligibility basics
- Ages 60+